hotspot -WSS

hotspot

author：leisure time 2025-10-01 15:28:14 - browse：64

Joe Biden in 2016. -- first opinion coverage from STAT — President Joe Biden Elise Amendola/AP

WASHINGTON — The latest phase of President Biden’s Cancer Moonshot initiative leaves open a few questions on how Congress might move forward with the program.

Since its launch in 2016, the federally funded cancer moonshot program has spurred thousands of scientific publications, 49 clinical trials, and more than 30 patent filings, according to a new report from the Congressional Research Service, the nonpartisan research arm of Congress.

The next phase of the cancer moonshot, according to Biden and his administration, is meant to emphasize cancer screening, prevention, and equitable treatment. The updated plan also seeks to speed progress on treatments for rare and childhood cancers, and it calls for supporting patients, survivors, and caregivers. The Advanced Research Projects Agency for Health (ARPA-H), a new agency tasked with taking big risks on biomedical and health technology, is also committing $240 million to cancer-related research and investing in new data-sharing platforms and a nationwide network for clinical trials.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

explore

WSS

Ebola: Gilead Sciences antiviral shows promise as new treatment

Medicare threatens to cut off funding for HCA's Mission hospital

The dental labor crisis is a moment of opportunity

Gilead might be held responsible for not developing a drug

The dental labor crisis is a moment of opportunity

KalVista pill reduced swelling 'attacks' caused by genetic disease

knowledge

hotspot

focus

Activists slam private health insurers over coverage restrictions

The dental labor crisis is a moment of opportunity

Alkermes shareholders re

Amid AI frenzy, a top HHS official's quest to create safeguards

BioMarin wins approval for gene therapy to treat hemophilia A

Private equity deals in Medicare Advantage declines

George Santos makes 1st court appearance after pleading not guilty to 13 counts

RaDonda Vaught links Vanderbilt hospital issues to patient death

Hepatitis C has a cure — but many Americans still lack access to it

A disappointing year of Humira biosimilars

entertainment

First U.S. drug developed to treat liver disease MASH is approved

Readout LOUD podcast: How biotech is using artificial intelligence

How digital tools helped lower hypertension in marginalized patients

Steward Health Care Massachusetts hospitals face fiscal disaster

Readout LOUD podcast: How biotech is using artificial intelligence

To avoid data mishandling cases, universities eye AI and other tools

explore

hotspot

explore

hotspot